Presenting Companies
-
OneMedForum New York is the definitive conference in North America for fast-growing and emerging healthcare and life science companies. This year, the conference focuses on burgeoning opportunities and operational strategies in Europe, and the relationship between Europe and North America within the international landscape. Now in its third year, the bi-annual forum invites companies with disruptive technology to connect with high-net worth strategic and financial investors in the space. Over 50 public and private companies will present their innovative technologies within a multimedia platform, both to large groups of targeted investors in person and streaming live on the internet. These presentations will follow six tracks, culminating in panels of key opinion leaders discussing the sectors on the cusp of significant change: Biotechnology, Diagnostics, Health Information, Medical Devices, Oncology and Regenerative Medicine. The forum will educate investors on the most important opportunities in the space, and introduce emerging companies to a privileged network of investors through unique meeting platforms, workshops and more.
- Company
- Description
- Recent News
Advaxis Incorporated
(OTCBB:ADXS)
[Micro-Cap Biotech/Device]- Advaxis is a biotechnology company developing the next generation of immunotherapies for cancer and infectious diseases. Advaxis immunotherapies are based upon a novel platform technology that utilizes live attenuated Listeria monocytogenes (Lm) bio-engineered to secrete an antigen/adjuvant fusion (Lm-LLO) protein.>>> Video Profile
- Advaxis Incorporated News And Presentations.
ADVENTRX Pharmaceuticals
(NYSE:AMEX:ANX)
[Micro-Cap Biotech/Device]- ADVENTRX Pharmaceuticals Inc. is an oncology- and hematology-focused specialty pharmaceutical company that acquires, develops, and commercializes proprietary product candidates.>>> Video Profile
- ADVENTRX Reports First Quarter 2012 Financial Results
ADVENTRX Pharmaceuticals to Sponsor & Present at the Martin Center’s 2012 Sickle Cell Disease Conference
Agile Therapeutics
(PRIVATE)
[Micro-Cap Biotech/Device]- Agile Therapeutics is a pharmaceutical development company specializing in Women’s Healthcare products, with an initial focus on providing women with more options and more convenient methods of hormonal contraception.>>> Video Profile
- New Studies On Agile Therapeutics’ Low-Dose Contraceptive Patch To Be Presented At The American College of Obstetricians And Gynecologists’ Annual Clinical Meeting.
Agile CEO Presents At Needham Healthcare Conference.
Amarantus Biosciences
(OTCBB:TNXP)
[Micro-Cap Biotech/Device]- Amarantus Therapeutics, formerly known as CNS Protein Therapeutics, is a privately-held biotechnology company that is developing first-in-class disease modifying treatments that address the underlying cause of cell death, known as apoptosis, associated with a wide range of diseases, including but not limited to, neurodegenerative and cardiovascular.>>> Video Profile
- Amarantus BioSciences Issues First Annual CEO Letter to Shareholders
Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
BioTime
(NYSE:BTIM)
[Micro-Cap Biotech/Device]- Biotime is a biotechnology company that has developed a broad biological platform that consists of commercially available biologics and stem cell products. >>> Video Profile
- BioTime Demonstrates Efficient Method for the Manufacture of Cartilage-Producing Cells from Human Embryonic Stem Cells
BioTime’s Subsidiary LifeMap Sciences, Inc. Presents Update on Product Development
Biovest International
(OTCPK:BVTI)
[Micro-Cap Biotech/Device]- Biovest International is a vertically integrated specialty biopharmaceutical company with services to commercialize targeted therapeutics, particularly for cancer. Biovest has a deep foundation in the manufacture of biological drugs from small research scale quantities to large volumes for Phase I and Phase II clinical material.>>> Video Profile
- Just a Shot in the Dark? The Promise of Cancer Vaccines
Immune Response Markers for Cancer Vaccines Paint a Clearer Picture
Brain Resource
(ASK:BRC)
[Micro-Cap Biotech/Device]- Brain Resource brings new insights and new efficiencies to managing brain health.>>> Video Profile
- Mental Gymnastics score on the job Business Insurance
Working with an Open Mind MarketWatch Story
ElectroCore Medical
(PRIVATE)
[Medical Devices and Technology]- ElectroCore Medical is a specialized medical devices company with a technological platform that utilizes therapeutic electro-stimulation. Much like the artificial heart pacemaker provides electrical stimulation to maintain a rhythmic heartbeat, the company aims to address other medical ailments by similar stimulation.
- 4/19/12 – ElectroCore® Receives Full FDA Approval for Acute Migraine Study
Endocrine Technology, LLC.
(PRIVATE)
[Medical Devices and Technology]- Endocrine Technology, LLC is a privately held company whose goal is to simplify the complexity of saving lives globally. This is done by developing products based on ETBond Technology.
Epion Health
(PRIVATE)
[Micro-Cap Biotech/Device]- Epion Health is improving the delivery of health care and health education through Smart Screen®.
Smart Screen® is a secure, easy to use tablet given to the patient after check-in for them to access health information while they are in the waiting room and exam room where the average wait time is 34 minutes.>>> Video Profile
Microvisk Limited
(PRIVATE)
[Micro-Cap Biotech/Device]- Microvisk has designed technology to carry out Prothrombin Time Assays, which determine the rate at which blood performs its necessary function of coagulation.>>> Video Profile
- New Board Appointments
Microvisk secures £6 million to launch World’s First Diagnostic SmartStrip® in 2011
NanoViricides, Inc.
(OTCBB: NNVC)
[Micro-Cap Biotech/Device]- NanoViricides Inc. is a pre-clinical biotech company that develops drugs to combat viral infections. >>> Video Profile
- NanoViricides Raises an Additional $5 Million in Shelf Offering – The Company Reports Having More than 24 Months of Cash in Hand
NanoViricides” Anti-Virus Technology Published in Bionanotechnology II: Global Prospects
Neurometrix
(NASDAQ:NURO)
[Micro-Cap Biotech/Device]- NeuroMetrix is a medical device company focused on the neurological complications of diabetes. Its products consist of medical devices and consumable biosensors.>>> Video Profile
- National Association of Managed Care Physicians
Ohio College of Pediatric Medicine Southern Exposure Conference
Novadaq Technologies, Inc.
(TSX:NDQ.TO)
[Micro-Cap Biotech/Device]- Novadaq Technologies develops and markets real-time fluorescence imaging technologies for usage in the operating room. >>> Video Profile
- Novadaq Reports First Quarter 2012 Financial Results
Novadaq to Present at Deutsche Bank 37th Annual Health Care Conference
OncoSec Medical
(OTCBB:ONCS.OB)
[Micro-Cap Biotech/Device]- OncoSec Medical is developing novel, localized therapies against solid tumors to overcome side effects associated with non-targeted approaches. >>> Video Profile
- OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer.
OncoSec Executive Team Contributes to Manufacturing Chemist and Company Profile Featured in San DiegoBusiness Journal.
Opexa Therapeutics
(NASDAQ:OPXA)
[Micro-Cap Biotech/Device]- Opexa Therapeutics (Nasdaq: OPXA) is a biotechnology company dedicated to the development of patient-specific cellular therapies for the treatment of autoimmune diseases such as multiple sclerosis (MS) and diabetes. >>> Video Profile
- Opexa to Hold Preliminary Investigator’s Meeting for MS Trial at American Academy of Neurology Annual Meeting
02/29/2012 – Opexa Therapeutics Executes Strategic Service Agreement with Pharmaceutical Research Associates to Manage Clinical Trial
Pluristem Therapeutics, Inc.
(NASDAQ:PSTI)
[Micro-Cap Biotech/Device]- Pluristem Therapeutics is a bio-therapeutics company dedicated to the commercialization of unrelated donor-patient (allogeneic) cell therapy products , derived from human placenta, for the treatment of several severe ischemic and autoimmune disorders.>>> Video Profile
- Cardiac Function in Pre-Clinical Diabetic Diastolic Heart Failure Subjects Improved by Pluristem’s PLX Cells
Compassionate Use of Pluristem’s PLX Cells Saves the Life of a Child after Bone Marrow Transplantation Failure
Provectus Pharmaceuticals
(OBB:PVCT)
[Micro-Cap Biotech/Device]- Provectus Pharmaceuticals specializes in developing oncology and dermatology therapies. Its novel oncology drug PV-10 is designed to selectively target and destroy cancer cells without harming surrounding healthy tissue, significantly reducing systemic side effects.>>> Video Profile
- Intralesional Therapies Discussed At the HemOnc Today Melanoma and Cutaneous Malignancies Meeting
PV-10, aka Rose Bengal: Intralesional Therapy For Metastatic Melanoma
Stroma Medical Corporation
(PRIVATE)
[Micro-Cap Biotech/Device]- Stroma Medical is a late development stage medical device company. Stroma uses a proprietary laser system to safely and effectively change the color of peoples eyes from brown or hazel to blue or green. The company has patents issued and pending.>>> Video Profile
Synthetic Biologics
(AMEX:SYN)
[Micro-Cap Biotech/Device]- Synthetic Biologics is a pharmaceutical company developing innovative medicines for the treatment of serious central nervous system diseases.>>> Video Profile
- Adeona Pharma Becomes Synthetic Biologics Thanks to New Angel Investment
Tianyin Pharmaceutical (TPI)
(NYSE:TPI)
[Micro-Cap Biotech/Device]- TPI is engaged in research, development, manufacturing, marketing and sale of patented biopharmaceutical, modernized TCMs, branded generics and other pharmaceuticals. >>> Video Profile
- TPI to Host Third Quarter of Fiscal Year 2012 Earnings Conference Call on Tuesday, May 15, 2012 at 9:00 a.m. ET
TPI Provides Progress Updates on its GMOL Flagship Product
Wound Management Technologies
(OTCPK:WNDM.PK)
[Micro-Cap Biotech/Device]- Wound Management Technologies Inc. is a provider of advanced biotech medical devices, with primary products in the $5B worldwide wound care market. >>> Video Profile
- New CellerateRX Quarter 3 2011 Newsletter Available for Download
Treating Diabetic Ulcers with CellerateRX AdvaMed 2011 Video Interview
ZymeWorks
(PRIVATE)
[Micro-Cap Biotech/Device]- Advaxis is a biotechnology company developing the next generation of immunotherapies for cancer and infectious diseases. Advaxis immunotherapies are based upon a novel platform technology that utilizes live attenuated Listeria monocytogenes (Lm) bio-engineered to secrete an antigen/adjuvant fusion (Lm-LLO) protein.>>> Video Profile
- Zymeworks Invited to Present at Leading Antibody Biology and Engineering Conference
View past presenting companies:
For more information, please contact OneMedPlace at forum@onemedplace.com or call 212.7841008